Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History PHIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics PHIO

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Phio Pharmaceuticals Corp

PHIO
Current price
2.49 USD 0 USD (0.00%)
Last closed 2.50 USD
ISIN US71880W5013
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 11 515 560 USD
Yield for 12 month -59.71 %
1Y
3Y
5Y
10Y
15Y
PHIO
21.11.2021 - 28.11.2021

Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts. Address: 11 Apex Drive, Marlborough, MA, United States, 01752

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

14.00 USD

P/E Ratio

Dividend Yield

Financials PHIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures PHIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-6 332 000 USD

Current Quarter

Last Quarter

EBITDA -7 048 500 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -43.43 %
PEG Ratio
Return On Equity TTM -76.12 %
Wall Street Target Price 14.00 USD
Revenue TTM
Book Value 2.55 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -3 669 000 USD
Earnings per share -9.02 USD
Diluted Eps TTM -9.02 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation PHIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.31
Enterprise Value Revenue 172.20
Price Sales TTM 48.01
Enterprise Value EBITDA 0.61
Price Book MRQ 0.97

Technical Indicators PHIO

For 52 Weeks

0.97 USD 9.79 USD
50 Day MA 2.11 USD
Shares Short Prior Month 226 845
200 Day MA 2.28 USD
Short Ratio 0.35
Shares Short 240 898
Short Percent 5.03 %